SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFM14A - Definitive proxy statement relating to merger or acquisition:
SEC Accession No. 0001628280-22-023926
Filing Date
2022-08-30
Accepted
2022-08-30 17:17:43
Documents
10

Document Format Files

Seq Description Document Type Size
1 DEFM14A a2022bhvnproxystatement-de.htm DEFM14A 3513085
2 annexb1a.jpg GRAPHIC 16478
3 annexb2a.jpg GRAPHIC 36589
4 biohavenlogo.jpg GRAPHIC 45274
5 biohavenpharmaceuticalhl001a.jpg GRAPHIC 158065
6 biohavenpharmaceuticalhl002a.jpg GRAPHIC 127175
7 douggraysignaturea.jpg GRAPHIC 2576
8 innisfree_awxlogoxrxrgb.jpg GRAPHIC 94963
9 picture1.jpg GRAPHIC 42626
10 vladcoricesiganturea.jpg GRAPHIC 16303
  Complete submission text file 0001628280-22-023926.txt   4251189
Mailing Address 215 CHURCH STREET NEW HAVEN CT 06510
Business Address 215 CHURCH STREET NEW HAVEN CT 06510 203-404-0410
Biohaven Pharmaceutical Holding Co Ltd. (Filer) CIK: 0001689813 (see all company filings)

IRS No.: 000000000 | State of Incorp.: D8 | Fiscal Year End: 1231
Type: DEFM14A | Act: 34 | File No.: 001-38080 | Film No.: 221215391
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences